World Leader in Genetic Risk Assessment
Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology.
Listed on the ASX(GTG) in 2000.
Listed on the NASDAQ (GENE) in 2005.
International R&D and commercialisation partner to:
-
universities
-
research organisations
-
progressive medical product distribution companies
Who we are
We are a molecular diagnostics company that offers predictive testing and assessment tools to empower physicians to proactively manage patient health
-
We empower individuals to manage and reduce their risk of contracting cancer and other chronic diseases
-
We strive to maintain our standing as a global leader in genomics
Our values
Dynamic
Proactive, striving, responsive and motivated
Professional
Punctual, trustworthy, accountable and respectful
Collaborative
Informative, receptive, transparent, cooperative
Passionate
Dedicated, enthusiastic, energetic, inspiring